No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US Stock MarketDetailed Quotes
CRXT CLARUS THERAPEUTICS HLDGS INC
- 0.000
- 0.0000.00%
15min DelayClose Dec 20 09:30 ET
0Market Cap0.00P/E (TTM)
0.000High0.000Low0Volume0.000Open0.000Pre Close0.00Turnover0.00%Turnover Ratio0.00P/E (Static)52.02MShares0.07552wk High0.00P/B0Float Cap0.04852wk Low--Dividend TTM37.52MShs Float31.240Historical High--Div YieldTTM0.00%Amplitude0.048Historical Low--Avg Price1Lot Size
Full Hours
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
No Data
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Clarus Therapeutics Holdings, Inc. Announces Completion of Auction for Sale of JATENZO® and Selection of Tolmar, Inc. as Successful Bidder
Testosterone Drug Maker Clarus Files For Bankruptcy -- Market Talk
Clarus Files for Chapter 11 Bankruptcy, Eyes Auction of Testosterone Therapy Jatenzo
Clarus Therapeutics: Jatenzo Auction Projected to End in Late October >CRXT
Clarus Therapeutics Seeks Authorization to Pursue Auction, Sale Process for Sole Commercial Asset Jatenzo >CRXT
Clarus Therapeutics Files Voluntary Petitions Under Chapter 11 >CRXT
Heat List
US
Overall
Symbol
Price
% Chg
No Data